Giampa', Carmela
 Distribuzione geografica
Continente #
NA - Nord America 516
EU - Europa 254
AS - Asia 138
OC - Oceania 2
AF - Africa 1
SA - Sud America 1
Totale 912
Nazione #
US - Stati Uniti d'America 511
CN - Cina 76
UA - Ucraina 73
IT - Italia 36
DE - Germania 30
IE - Irlanda 30
SG - Singapore 28
SE - Svezia 26
ID - Indonesia 18
FI - Finlandia 17
RU - Federazione Russa 14
BE - Belgio 8
FR - Francia 7
GB - Regno Unito 6
HK - Hong Kong 6
CA - Canada 4
JP - Giappone 4
AU - Australia 2
IN - India 2
PL - Polonia 2
AE - Emirati Arabi Uniti 1
BG - Bulgaria 1
BR - Brasile 1
BY - Bielorussia 1
CH - Svizzera 1
DK - Danimarca 1
EG - Egitto 1
GR - Grecia 1
KR - Corea 1
MX - Messico 1
TR - Turchia 1
VN - Vietnam 1
Totale 912
Città #
Chandler 145
Ann Arbor 34
Beijing 34
Jacksonville 33
Dublin 30
Singapore 25
Ashburn 22
Cattolica 22
Wilmington 22
Munich 20
Boston 18
Jakarta 18
Lawrence 17
San Mateo 16
Moscow 11
Fairfield 10
Brussels 8
Mountain View 7
Seattle 7
Boardman 6
Hong Kong 6
Nanchang 6
Nanjing 6
Woodbridge 6
Hangzhou 5
Milan 5
Shenyang 5
Redwood City 4
University Park 4
Yalta 4
Falls Church 3
Jiaxing 3
Norwalk 3
Changsha 2
Edinburgh 2
Fremont 2
Hebei 2
Jalgaon 2
Kraków 2
Mcallen 2
Rome 2
Salt Lake City 2
Shanghai 2
Simi Valley 2
Tokyo 2
Böblingen 1
Cairo 1
Changzhi 1
Chelyabinsk 1
Clearwater 1
Dubai 1
Frederiksberg 1
Gatchina 1
Halifax 1
Harbin 1
Houston 1
Izmir 1
Kingston 1
Lanzhou 1
Leawood 1
Los Angeles 1
Marseille 1
Melbourne 1
Mexico City 1
Monmouth Junction 1
Orlando 1
Princeton 1
San Francisco 1
Seoul 1
Sessa Aurunca 1
Shenzhen 1
Sofia 1
St Petersburg 1
Tappahannock 1
Tianjin 1
Toronto 1
Winnipeg 1
Yellow Springs 1
Zhengzhou 1
Zurich 1
Totale 624
Nome #
Erratum: Persistent activation of microglia and NADPH oxidase drive hippocampal dysfunction in experimental multiple sclerosis (Scientific Reports (2016) 6 (20926) DOI: 10.1038/srep20926) 62
Endogenous 17β-estradiol is required for activity-dependent long-term potentiation in the striatum: interaction with the dopaminergic system. 60
Phosphodiesterases as therapeutic targets for Huntington's disease. 57
Derangement of Ras-guanine nucleotide-releasing factor 1 (Ras-GRF1) and extracellular signal-regulated kinase (ERK) dependent striatal plasticity in L-DOPA-induced dyskinesia. 56
Alpha-Synuclein Produces Early Behavioral Alterations via Striatal Cholinergic Synaptic Dysfunction by Interacting With GluN2D N-Methyl-D-Aspartate Receptor Subunit 55
Effects of central and peripheral inflammation on hippocampal synaptic plasticity 54
Rhes influences striatal cAMP/PKA-dependent signaling and synaptic plasticity in a gender-sensitive fashion 53
PARP-1 Inhibition Is Neuroprotective in the R6/2 Mouse Model of Huntington's Disease 52
Systemic delivery of recombinant brain derived neurotrophic factor (BDNF) in the R6/2 mouse model of Huntington's disease 51
The distinct role of medium spiny neurons and cholinergic interneurons in the D₂/A₂A receptor interaction in the striatum: implications for Parkinson's disease 51
Inhibition of phosphodiesterases rescues striatal long-term depression and reduces levodopa-induced dyskinesia 50
Ischemic-LTP in striatal spiny neurons of both direct and indirect pathway requires the activation of D1-like receptors and NO/soluble guanylate cyclase/cGMP transmission 47
Conditioned medium from amniotic cells protects striatal degeneration and ameliorates motor deficits in the R6/2 mouse model of Huntington's disease 46
A2A adenosine receptor antagonism enhances synaptic and motor effects of cocaine via CB1 cannabinoid receptor activation 45
Rebalance of striatal NMDA/AMPA receptor ratio underlies the reduced emergence of dyskinesia during D2-like dopamine agonist treatment in experimental Parkinson's disease 45
Phosphodiesterase 10A (PDE10A) localization in the R6/2 mouse model of Huntington's disease 45
Dopamine-dependent long-term depression is expressed in striatal spiny neurons of both direct and indirect pathways: implications for Parkinson's disease 45
Inhibition of the striatal specific phosphodiesterase PDE10A ameliorates striatal and cortical pathology in R6/2 mouse model of Huntington's disease 43
Totale 917
Categoria #
all - tutte 5.232
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.232


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202051 0 0 0 0 0 0 0 0 2 16 15 18
2020/2021117 8 17 0 17 17 2 11 3 22 2 14 4
2021/2022100 3 15 2 2 3 12 3 9 3 6 18 24
2022/2023287 23 42 22 38 34 40 1 27 44 1 10 5
2023/2024116 8 60 1 3 0 2 7 8 1 3 9 14
2024/202565 11 7 18 7 14 8 0 0 0 0 0 0
Totale 917